IP Verse

Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material - EP2945962B1

PatentPatent Analysis

EP2945962

PROTHERA BIOLOGICS
Application Number
EP14740523A
Filing Date
Jan 17, 2014
Status
Revoked
Jun 23, 2023
Grant Date
Apr 17, 2019
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2945962B1 was granted to Prothera Biologics on Apr 17, 2019 following the initial filing on Jan 17, 2014 under the application number EP14740523A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTJan 17, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents